Listen

Description

CHI president Phillips Kuhl and Sequenom CMO Daniel Grosu discuss how Sequenom is applying new technology to address the next sets of clinical questions for non-invasive prenatal testing.

To learn more, please visit http://www.MolecularDXEurope.com/